Eptacog alfa pegol (activated) Completed Phase 1 Trials for Haemophilia B / Hemophilia A / Congenital Hematological Disorder / Healthy Volunteers Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00951873A Single Dose Trial Investigating Safety and Local Tolerability of Ascending Doses of Long Acting Activated Recombinant Human Factor VII in Healthy Male Volunteers